ArticleFrontiers in microbiology2021
Co-occurrence of
Article in Frontiers in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 26 citations in OpenAlex.
- Dual resistance to carbapenems and colistin inEmerging microbes & infections · 2026Article
- Dissemination of a IncHI2A plasmid co-harboring the mcr-9 and blaAnnals of clinical microbiology and antimicrobials · 2025Article
- Emergence of concurrently transmissibleMicrobiology spectrum · 2025Article
- Dissemination of IncQ1 Plasmids Harboring NTEMicroorganisms · 2025Article
- Silent spread of mcr-9 in ESBL-producing Enterobacteriaceae clinical isolates, Jimma, Ethiopia.PloS one · 2025Article
- Emerging Mobile Colistin Resistance GeneInfection and drug resistance · 2025Article
- Integrated Analysis of Patient Networks and Plasmid Genomes to Investigate a Regional, Multispecies Outbreak of Carbapenemase-Producing Enterobacterales Carrying Both blaIMP and mcr-9 Genes.The Journal of infectious diseases · 2024Article
- Genomic analysis of carbapenem- and colistin-resistant Klebsiella pneumoniae complex harbouring mcr-8 and mcr-9 from individuals in Thailand.Scientific reports · 2024Article
- In vitro and in vivo activity of ceftazidime/avibactam and aztreonam alone or in combination against mcr-9, serine- and metallo-β-lactamases-co-producing carbapenem-resistant Enterobacter cloacae complex.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024Article
- First report ofMicrobiology spectrum · 2024Article
- A multiplex TaqMan real-time PCR assays for the rapid detection of mobile colistin resistance (Frontiers in microbiology · 2024Article
- Article
- First report of coexistence ofFrontiers in microbiology · 2023Article
- Convergence of plasmid-mediated Colistin and Tigecycline resistance inFrontiers in microbiology · 2023Article
- Epidemiology and genomic analysis of Klebsiella oxytoca from a single hospital network in Australia.BMC infectious diseases · 2022Article
- Occurrence ofAntibiotics (Basel, Switzerland) · 2022Article
- Emergence of Neonatal Sepsis Caused by MCR-9- and NDM-1-Co-ProducingFrontiers in cellular and infection microbiology · 2022Article
- Molecular antibiotic resistance mechanisms and co-transmission of theFrontiers in microbiology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Spread of the carbapenemase-encoding and mobilized colistin resistance (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.